Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

International Neuromodulation Society invites media to satellite-event news briefing before 12th World Congress

Representatives of the news media are invited to a satellite-event news briefing at 11 a.m. on June 6, 2015 before the International Neuromodulation Society 12th World Congress in Montreal.

1 Jun 2015

Connect.Parkinson national research study achieves enrollment target

The National Parkinson Foundation (NPF) announced today that the Connect.Parkinson national research study, comparing telemedicine care delivered to remote patients from a Parkinson's disease center of excellence to community-based care for Parkinson's disease, has achieved its enrollment target.

1 Jun 2015

FVCG portfolio companies selected to present research at Bio International 2015

Actinobac Biomed, NovoPedics, Inc. and MentiNova, Inc., three biotech start-up companies originally funded with investments from Foundation Venture Capital Group (FVCG), have been selected to present their research at Bio International 2015 as part of the Start-Up Stadium and Company Presentation forums offered at the Conference, announced FVCG President James M. Golubieski.

30 May 2015

People with cognitive impairment have altered responses to pain

People with dementia and other forms of cognitive impairment (CI) have altered responses to pain, with many conditions associated with increased pain sensitivity, concludes a research review in PAIN, the official publication of the International Association for the Study of Pain.

29 May 2015

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

Some decisions arouse far more anxiety than others. Among the most anxiety-provoking are those that involve options with both positive and negative elements, such choosing to take a higher-paying job in a city far from family and friends, versus choosing to stay put with less pay.

29 May 2015

People with MS have much greater risk of dying younger compared to people without MS

New research suggests people with multiple sclerosis (MS) may have double the risk of dying early compared to people without MS, with those younger than 59 at a three times higher risk. The study is published in the May 27, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 May 2015

Scorpion venom could kill cancer cells

When the toxin invades channels in the cells with this disease produces cellular damage until killing them.

27 May 2015

UF research opens door to better diagnosis and treatment of Parkinson's disease

University of Florida researchers have identified a biomarker that shows the progression of Parkinson's disease in the brain, opening the door to better diagnosis and treatment of the degenerative disease.

27 May 2015

Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

People with depression may be more likely to develop Parkinson's disease, according to a large study by researchers at Umeå University, Sweden, published on 20 May, 2015, in the online issue of Neurology, the medical journal of the American Academy of Neurology.

21 May 2015

New findings could help better understand neurodegenerative diseases

Researchers at the Luxembourg Centre for Systems Biomedicine (LCSB), of the University of Luxembourg, have, under Dr. Manuel Buttini, successfully measured metabolic profiles, or the metabolomes, of different brain regions, and their findings could help better understand neurodegenerative diseases.

18 May 2015

Researchers explore how low-level electrical stimulation reduces inflammation

The Feinstein Institute for Medical Research, the research arm of the North Shore-LIJ Health System, and SetPoint Medical Inc., a biomedical technology company, today released the results of research on the therapeutic potential of vagus nerve stimulation. In a paper published by Bioelectronic Medicine, Kevin J. Tracey, MD, and his colleagues at the Feinstein Institute, explore how low-level electrical stimulation interacts with the body's nerves to reduce inflammation, a fundamental goal of bioelectronic medicine.

15 May 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali Therapeutics Inc., a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million.

14 May 2015

New work challenges long-held beliefs about link between hippocampus and improved memory function

New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function.

14 May 2015

Miniature, fiber-optic microscope allows deep brain exploration

A team of neuroscientists and bioengineers at the University of Colorado Anschutz Medical Campus have created a miniature, fiber-optic microscope designed to peer deeply inside a living brain.

14 May 2015

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.

12 May 2015

New method may help determine potential indicator of stress, neurological disorders

A research collaboration between the universities of Oslo and Aarhus has resulted in the development of a new method with diagnostic potential. The new method that combines phase extraction with an enzymatic reaction may eventually be used for an improved and faster screening analysis of isatin as a potential indicator of stress and neurological disorders.

12 May 2015

Experts to discuss impact of telemedicine on care delivery for aging Americans at d.health Summit

Recent technological, legal, and clinical developments are leading to dramatic changes in the ways medical care is delivered. While this shift has the power to displace many well-established healthcare players, it also presents an opportunity to form new partnerships and business alliances among industry leaders and newcomers to improve and enhance healthcare delivery.

11 May 2015

MJFF announces acquisition of parkin research tools from Imago Pharmaceuticals

The Michael J. Fox Foundation for Parkinson's Research announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and drug development against this promising disease-modification target.

11 May 2015

β-amyloid deposition highly variable in synucleinopathy

A meta-analysis suggests large variability in the prevalence of β-amyloid deposition in patients with synucleinopathies.

8 May 2015

Olfactory bulb changes fall short as imaging marker for PD

Functional and histopathological changes in the olfactory bulb in patients with Parkinson’s disease do not equate to a volume change that is detectable on magnetic resonance imaging, say researchers.

8 May 2015

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

International Neuromodulation Society invites media to satellite-event news briefing before 12th World Congress

Connect.Parkinson national research study achieves enrollment target

FVCG portfolio companies selected to present research at Bio International 2015

People with cognitive impairment have altered responses to pain

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

People with MS have much greater risk of dying younger compared to people without MS

Scorpion venom could kill cancer cells

UF research opens door to better diagnosis and treatment of Parkinson's disease

Depression may be a risk factor for Parkinson's disease, say Umeå University researchers

New findings could help better understand neurodegenerative diseases

Researchers explore how low-level electrical stimulation reduces inflammation

Denali launched to discover, develop effective medicines for neurodegenerative diseases

New work challenges long-held beliefs about link between hippocampus and improved memory function

Miniature, fiber-optic microscope allows deep brain exploration

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

New method may help determine potential indicator of stress, neurological disorders

Experts to discuss impact of telemedicine on care delivery for aging Americans at d.health Summit

MJFF announces acquisition of parkin research tools from Imago Pharmaceuticals

β-amyloid deposition highly variable in synucleinopathy

Olfactory bulb changes fall short as imaging marker for PD

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in